Campus Units

Chemical and Biological Engineering, Nanovaccine Institute

Document Type

Article

Research Focus Area

Health Care Technology and Biomedical Engineering

Publication Version

Accepted Manuscript

Publication Date

4-2020

Journal or Book Title

Trends in Biotechnology

Volume

38

Issue

4

First Page

388

Last Page

403

DOI

10.1016/j.tibtech.2019.11.001

Abstract

Dynamic immunoimaging in vivo is crucial in patient-tailored immunotherapies to identify patients who will benefit from immunotherapies, monitor therapeutic efficacy post treatment, and determine alternative strategies for nonresponders. Nanoparticles have played a major role in the immunotherapy landscape. In this review, we summarize recent findings in immunoimaging where smart nanoparticles target, detect, stimulate, and deliver therapeutic dose in vivo. Nanoparticles interfaced with an immunoimaging toolbox enable the use of multiple modalities and achieve depth-resolved whole-body tracking of immunomarkers with high accuracy both before and after treatment. We highlight how functional nanoparticles track T cells, dendritic cells (DCs), tumor-associated macrophages (TAMs), and immune checkpoint receptors (ICRs), and facilitate image-guided interventions.

Comments

This is a manuscript of an article published as Ou, Yu-Chuan, Xiaona Wen, and Rizia Bardhan. "Cancer Immunoimaging with Smart Nanoparticles." Trends in Biotechnology 38, no. 4 (2020): 388-403. DOI: 10.1016/j.tibtech.2019.11.001. Posted with permission.

Copyright Owner

Elsevier Ltd.

Language

en

File Format

application/pdf

Published Version

Share

COinS